Abstract
In an attempt to find potential neuroprotective agents, a series of novel 3-(1-((1-(substituted phenyl)-1H-1,2,3-triazol-4-yl) methoxyimino) ethyl)-2H-chromen-2-one derivatives 6a–j were synthesized by using “click reaction” and evaluated for their in vitro neuroprotectivity and toxicity against H2O2-induced PC12 cell lines by using MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) reduction assay. Most of them exhibited moderate to good activity in which compound 6e was found to have significant protectivity with cell viability of 94.51 ± 0.68% at 50 µg/ml concentration and half-maximal effective concentration (EC50) value of 14.04 µg/ml against injured PC12 cell lines and low toxicity with half-maximal cytotoxic concentration (CC50) value of 544.88 µg/ml. Furthermore, molecular docking was carried out in order to understand plausible binding modes of novel derivatives with the active site of glycogen synthase kinase-3β enzyme, and the results were well complemented by the in vitro neuroprotective results against H2O2-induced PC12 cell lines. Additionally, in silico ADME properties showed drug likeness with good oral absorption and moderate blood–brain barrier permeability. The structures of all the synthesized compounds were confirmed by 1H NMR, 13C NMR, IR and LC–MS analyses.
Similar content being viewed by others
References
G.C. Gonzalez-Munoz, M.P. Arce, M.G. Lopez, B. Lopez, C. Perez, M. Villarroya, M.G. Lopez, A.G. Garcia, S. Conde, M.I.R. Franco, Eur. J. Med. Chem. 45, 6152 (2010)
D. Pratico, Trends Pharmacol. Sci. 29, 609 (2008)
K.J. Barnham, C.L. Masters, A.I. Bush, Nat. Rev. Drug Discov. 3, 205 (2004)
S.F. Wang, Y. Yin, X. Wu, F. Qiao, S. Sha, P.C. Lv, J. Zhao, H.L. Zhu, Bioorg. Med. Chem. 22, 5727 (2014)
Q. Ji, Z. Ge, Z. Ge, K. Chen, H. Wu, X. Liu, Y. Huang, L. Yuan, X. Yang, F. Liao, Eur. J. Med. Chem. 108, 166 (2016)
W. Zhang, Z. Li, M. Zhou, F. Wu, X. Hou, H. Luo, H. Liu, X. Han, G. Yan, Z. Ding, R. Li, Bioorg. Med. Chem. Lett. 24, 799 (2014)
M.Z. Hassan, H. Osman, M.A. Ali, M.J. Ahsan, Eur. J. Med. Chem. 123, 236 (2016)
T.O. Olomola, R. Klein, N. Mautsa, Y. Sayed, P.T. Kaye, Bioorg. Med. Chem. 21, 1964 (2013)
L. Lei, Y.B. Xue, Z. Liu, S.S. Peng, Y. He, Y. Zhang, R. Fang, J.P. Wang, Z.W. Luo, G.M. Yao, J.W. Zhang, G. Zhang, H.P. Song, Y.H. Zhang, Sci. Rep. 5, 13544 (2015)
M. Khoobi, S. Emami, G. Dehghan, A. Foroumadi, A. Ramazani, A. Shafiee, Arch. Pharm. Chem. Life Sci. 344, 588 (2011)
E. Grimm, C. Brideau, N. Chauret, C. Chan, D. Delorme, Y. Ducharme, D. Ethier, J. Falgueyret, R. Friesen, J. Guay, P. Hamel, D. Riendeau, C.S. Breau, P. Tagari, Y. Girard, Bioorg. Med. Chem. Lett. 16, 2528 (2006)
D.H. Dawood, R.Z. Batran, T.A. Farghaly, M.A. Khedr, M.M. Abdulla, Arch. Pharm. Chem. Life Sci. 348, 875 (2015)
S. Manfredini, C.B. Vicentini, M. Manfrini, N. Bianchi, C. Rutigliano, C. Mischiati, R. Gambari, Bioorg. Med. Chem. 8, 2343 (2000)
K. Lal, P. Yadav, A. Kumar, Med. Chem. Res. 25, 644 (2016)
É. Bokor, T. Docsa, P. Gergely, L. Somsák, Bioorg. Med. Chem. 18, 1171 (2010)
T.W. Kim, Y. Yong, S.Y. Shin, H. Jung, K.H. Park, Y.H. Lee, Y. Lim, K.Y. Jung, Bioorg. Chem. 59, 1 (2015)
J.L. Kelley, C.S. Koble, R.G. Davis, E.W. McLean, F.E. Soroko, B.R. Coopert, J. Med. Chem. 38, 4131 (1996)
P. Passannanti, P. Diana, F. Barraja, A. Mingoia, G. Lauria, Cirrincione. Heterocycles 48, 1229 (1998)
N. Devender, S. Gunjan, S. Chhabra, K. Singh, V.R. Pasam, S.K. Shukla, A. Sharma, S. Jaiswal, S.K. Singh, Y. Kumar, J. Lal, A.K. Trivedi, R. Tripathi, R.P. Tripathi, Eur. J. Med. Chem. 109, 187 (2016)
A.K. Jordao, P.P. Afonso, V.F. Ferreira, M.C.B.V. de Souza, M.C.B. Almeida, C.O. Beltrame, D.P. Paiva, S.M.S.V. Wardell, J.L. Wardell, E.R.T. Tiekink, C.R. Damaso, A.C. Cunha, Eur. J. Med. Chem. 44, 3777 (2009)
M. Sun, J. Hu, X. Song, D. Wu, L. Kong, Y. Sun, D. Wang, Y. Wang, N. Chen, G. Lui, Eur. J. Med. Chem. 67, 39 (2013)
A. Asadipour, M. Alipour, M. Jafari, M. Khoobi, S. Emami, H. Nadri, A. Sakhteman, A. Moradi, V. Sheibani, F.H. Moghadam, A. Shafiee, A. Foroumadi, Eur. J. Med. Chem. 70, 623 (2013)
C. Hooper, R. Killick, S. Lovestone, J. Neurochem. 104(6), 1433 (2008)
Mudasir Maqbool, Mohammad Mobashir, Nasimul Hoda, Eur. J. Med. Chem. 107, 63 (2016)
G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, A.J. Olson, J. Comput. Chem. 30, 2785 (2009)
E. ter Haar, J.T. Coll, D.A. Austen, H.M. Hsiao, L. Swenson, J. Jain, Nat. Struct. Biol. 8, 593 (2001)
E.F. Pettersen, T.D. Goddard, C.C. Huang et al., J. Comput. Chem. 25, 1605 (2004)
Y. Zhao, M.H. Abraham, J. Lee, A. Hersey, N.C. Luscombe, G. Beek, B. Sherborne, I. Cooper, Pharm. Res. 19, 1446 (2002)
G. Walkinshaw, C.M. Waters, Neuro Science 63, 975 (1994)
I.Z. Tao, X.F. Li, I.I. Zhang, J.Y. Tian, X.B. Li, X. Sun, X.F. Li, I. Jiang, X.J. Zhang, J.Z. Chen, PLoS ONE 6, 1 (2011)
H. Garn, H. Krause, V. Enzmann, K. Drassler, Immunol. Method 168, 253 (1994)
S.M. Thom, R.W. Horobin, E. Seidler, M.R. Barer, Appl. Bacteriol. 74, 433 (1993)
G. Vistoli, A. Pedretti, B. Testa, Drug Discov. Today 13(7–8), 285 (2008)
C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeny, Adv. Drug Deliv. Rev. 23, 3 (1997)
D.E. Clark, S.D. Pickett, Drug Discov. Today 5, 49 (2000)
Acknowledgements
One of the authors (MAK) gratefully acknowledges UGC for providing financial assistance in the form of a BSR fellowship. Funding was provided by University Grants Commission (Grant No. F.25-1/2013-14 (BSR)/7-187/2007 (BSR)).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumari, M.A., Rao, C.V., Triloknadh, S. et al. Synthesis, docking and ADME prediction of novel 1,2,3-triazole-tethered coumarin derivatives as potential neuroprotective agents. Res Chem Intermed 44, 1989–2008 (2018). https://doi.org/10.1007/s11164-017-3210-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-017-3210-2